Exponent, Inc. (EXPO) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its position in Exponent, Inc. (NASDAQ:EXPO) by 3.9% during the first quarter, Holdings Channel reports. The firm owned 2,176,141 shares of the business services provider’s stock after buying an additional 81,811 shares during the period. Vanguard Group Inc. owned approximately 0.08% of Exponent worth $129,590,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in shares of Exponent during the fourth quarter worth approximately $14,612,000. Confluence Investment Management LLC raised its position in shares of Exponent by 10.0% in the first quarter. Confluence Investment Management LLC now owns 43,736 shares of the business services provider’s stock worth $2,605,000 after buying an additional 3,971 shares during the period. Bank of Montreal Can raised its position in shares of Exponent by 21.8% in the first quarter. Bank of Montreal Can now owns 3,209 shares of the business services provider’s stock worth $192,000 after buying an additional 575 shares during the period. Louisiana State Employees Retirement System raised its position in shares of Exponent by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 10,400 shares of the business services provider’s stock worth $619,000 after buying an additional 100 shares during the period. Finally, Conestoga Capital Advisors LLC raised its position in shares of Exponent by 7.5% in the first quarter. Conestoga Capital Advisors LLC now owns 628,897 shares of the business services provider’s stock worth $37,451,000 after buying an additional 43,615 shares during the period. Institutional investors own 90.10% of the company’s stock.

Shares of Exponent, Inc. (NASDAQ:EXPO) opened at 65.80 on Wednesday. The company has a market capitalization of $1.74 billion, a PE ratio of 34.11 and a beta of 0.60. Exponent, Inc. has a 52-week low of $48.42 and a 52-week high of $68.30. The stock’s 50 day moving average price is $59.54 and its 200-day moving average price is $59.14.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Tuesday, July 18th. The business services provider reported $0.51 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.10. Exponent had a return on equity of 16.52% and a net margin of 15.94%. The company had revenue of $84.10 million during the quarter, compared to analysts’ expectations of $79.30 million. During the same period last year, the firm posted $0.38 earnings per share. The business’s revenue was up 14.7% on a year-over-year basis. On average, analysts expect that Exponent, Inc. will post $1.97 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 22nd. Stockholders of record on Friday, September 1st will be given a $0.21 dividend. The ex-dividend date is Wednesday, August 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.28%. Exponent’s payout ratio is 43.52%.

COPYRIGHT VIOLATION WARNING: This article was first posted by BBNS and is owned by of BBNS. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://baseballnewssource.com/markets/exponent-inc-expo-shares-bought-by-vanguard-group-inc/1282504.html.

EXPO has been the subject of a number of research analyst reports. Zacks Investment Research lowered Exponent from a “buy” rating to a “hold” rating in a report on Wednesday, April 19th. Cantor Fitzgerald reiterated an “overweight” rating and set a $69.00 price target (up from $64.00) on shares of Exponent in a report on Saturday, April 22nd. BidaskClub lowered Exponent from a “hold” rating to a “sell” rating in a report on Tuesday, June 20th. Finally, ValuEngine upgraded Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th.

In related news, insider Sally Shepard sold 1,255 shares of Exponent stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $65.37, for a total transaction of $82,039.35. Following the completion of the sale, the insider now directly owns 1,560 shares of the company’s stock, valued at approximately $101,977.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider John Pye sold 3,600 shares of Exponent stock in a transaction that occurred on Monday, July 24th. The stock was sold at an average price of $65.08, for a total value of $234,288.00. Following the sale, the insider now directly owns 14,767 shares of the company’s stock, valued at $961,036.36. The disclosure for this sale can be found here. Company insiders own 2.80% of the company’s stock.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Giancarlo Stanton Continues Record Pace for July
Giancarlo Stanton Continues Record Pace for July
Los Angeles Dodgers Ace Clayton Kershaw to Go on DL
Los Angeles Dodgers Ace Clayton Kershaw to Go on DL
Colin Moran Fouls Ball Off Eye, Taken to Hospital
Colin Moran Fouls Ball Off Eye, Taken to Hospital
Chris Sale Reaches 200 Strikeouts in Record Time
Chris Sale Reaches 200 Strikeouts in Record Time
Veteran Pitcher Bartolo Colon Considering Retirement
Veteran Pitcher Bartolo Colon Considering Retirement
Todd Frazier Traded to Yankees for Blake Rutherford and Others
Todd Frazier Traded to Yankees for Blake Rutherford and Others


Leave a Reply

 
© 2006-2017 BBNS.